Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537686) titled 'Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)' on April 12.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh

Condition: Environmental Enteric Dysfunction

Intervention: Drug: Teduglutide 0.05 dose...

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: July 1, 2026

Target Sample Size: 55

To know more, visit ...